Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors

Por Mueller, Daniela, Krug, Sebastian, Majumder, Moushumee, Rinke, Anja, Gress, Thomas Matthias
Publicado no BMC Cancer (2016)

Streptozocin-Based Chemotherapy in Patients with Advanced Neuroendocrine Neoplasms – Predictive and Prognostic Markers for Treatment Stratification

Por Krug, Sebastian, Boch, Michael, Daniel, Hanna, Nimphius, Wilhelm, Müller, Daniela, Michl, Patrick, Rinke, Anja, Gress, Thomas Matthias
Publicado no PLoS One (2015)